Cargando…
Endothelin Receptor Blocker Reverses Breast Cancer–Induced Cardiac Remodeling
BACKGROUND: Although some cancer therapies have overt and/or subclinical cardiotoxic effects that increase subsequent cardiovascular risk in breast cancer patients, we have recently shown that the breast tumor itself can also induce cardiac hypertrophy through the activation of the endothelin system...
Autores principales: | Maayah, Zaid H., Ferdaoussi, Mourad, Boukouris, Aristeidis E., Takahara, Shingo, Das, Subhash K., Khairy, Mostafa, Mackey, John R., Pituskin, Edith, Sutendra, Gopinath, Paterson, D. Ian, Dyck, Jason R.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635889/ https://www.ncbi.nlm.nih.gov/pubmed/37969640 http://dx.doi.org/10.1016/j.jaccao.2023.02.004 |
Ejemplares similares
-
Breast cancer diagnosis is associated with relative left ventricular hypertrophy and elevated endothelin-1 signaling
por: Maayah, Zaid H., et al.
Publicado: (2020) -
Chronic exogenous ketone supplementation blunts the decline of cardiac function in the failing heart
por: Takahara, Shingo, et al.
Publicado: (2021) -
Metabolomic Fingerprint of Behavioral Changes in Response to Full-Spectrum Cannabis Extracts
por: Maayah, Zaid H., et al.
Publicado: (2022) -
p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology
por: Saleme, Bruno, et al.
Publicado: (2020) -
Endotheliitis, endothelin, and endothelin receptor blockers in COVID-19
por: Sanghavi, Devang K., et al.
Publicado: (2021)